Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1 IPO registration
- 2.1 EX-2.1
- 3.1 EX-3.1
- 3.3 EX-3.3
- 10.1 EX-10.1
- 10.2 EX-10.2
- 10.3 EX-10.3
- 10.4 EX-10.4
- 10.5 EX-10.5
- 10.12 EX-10.12
- 10.13 EX-10.13
- 10.14 EX-10.14
- 10.15 EX-10.15
- 10.16 EX-10.16
- 10.17 EX-10.17
- 10.18 EX-10.18
- 10.19 EX-10.19
- 10.20 EX-10.20
- 10.21 EX-10.21
- 10.22 EX-10.22
- 10.23 EX-10.23
- 10.24 EX-10.24
- 23.1 EX-23.1
- 23.3 EX-23.3
- 23.4 EX-23.4
- 23.5 EX-23.5
- EX-FILING FEES Ex-filing Fees
Associated filings
- 4 Jan 23 RW Registration withdrawal request
-
21 Sep 22 S-1 IPO registration
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the use in this Registration Statement on Form S-1 and related Prospectus of Melt Pharmaceuticals, Inc. (the “Company”) of our report dated April 1, 2022 (except for the Leases section of Note 5, as to which the date is May 18, 2022) (which report contains an explanatory paragraph relating to the Company’s ability to continue as a going concern) relating to the financial statements of the Company.
We also consent to the reference to our firm under the caption “Experts” in such Registration Statement.
/s/ KMJ Corbin & Company LLP
Irvine, California
September 21, 2022